Fusion event
HBV-LYPLAL1-DT integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Integrated sequence
GTTGATGCCTTTGTATGCATGTATTCAATCTAAGCAGGCTTTCACTTTCTCGCCAACTTACAAGGCCTTTCTGTGTAAACAATACCTGAACCTTTACCCC| |GTTGCCCGGCAACGGCCAGGTCTGTGCCAAGTGTTTGCTGACGCAACCCCCACTGGCTGGGGCTTGGTCATGGGCCATCAGCGCATGCGTGGAACCTTTT
End
219315301/219141959 (Hg38)
Location type
ncRNA_intronic
Nearest miRNA
hsa-mir-101-1/Upstream/7064274; hsa-mir-1182/Downstream/975894;
Upstream sequence
GCCTGGGGTCACAAATGAATTCTATGGAGCTGTGACAACAGACTCAGGACCAGCGTGGATAATGCCATGGAGTCCCTGCCTCCCCTGTGATTACCCATTC
Downstream sequence
CTTCAGTTCTCAAAGGCTGTGGAAGCATCTGAAGAACAAAAAGCACAGGTGTAAATTGCTGAATACCATTCAGGTGGCTAAAAAAAGCCATCACTGGTTG
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.